Life Sciences Artificial Intelligence (AI) Market - Forecast(2021 - 2026)

Report Code: ITR 0175 Report Format: PDF + Excel (Delivery in 48 Hrs)

Life Sciences Artificial Intelligence (AI) Market Overview

The global Life Sciences AI Market size is estimated to surpass $324.2 million mark by 2026 growing at an estimated CAGR of more than 13.1% during the forecast period 2021 to 2026. Life Sciences Artificial Intelligence provides potential to improve the health care system especially personalized medicine and drug development. With the implementation of AI it becomes possible for the healthcare organization to drive innovation and achieve various outcomes including hyper-personalized experiences, new sources of growth, and new levels of efficiency. In 2019, the adoption of technologies such as AI has reshaped the life science industry. The innovation in the life science industry will also lead to provide growing potential for healthcare organizations. Artificial Intelligence is proved to be an advanced tool which is reshaping the Life Sciences industry. The rising application in initiating drug discovery and development is fuelling the need for Life Sciences AI industry.

Report Coverage

The report: “Life Sciences AI Industry Outlook– Forecast (2021-2026)”, by IndustryARC covers an in-depth analysis of the following segments of the Life Sciences AI Market.
By Process: First Wave, Second Wave and Third Wave.
By Type: Machine Learning, Deep Learning and Neural Networks.
By End Use Industry: Drug Discovery,  Pre–Clinical, Clinical, Drug Approval, Patient Monitoring and Others.
By Geography - North America (U.S, Canada, Mexico),  Europe (Germany, UK, France, Italy, Spain, Russia and Others), APAC(China, Japan India, SK, Aus and Others), South America(Brazil, Argentina and others), and RoW (Middle East and Africa).

Key Takeaways

  • What can be automated, will be automated - initially, there were several steps of drug development and clinical research which are very expensive to perform, which took time and were labor demanding. If pharmaceutical companies starts different stages along with automation automatically it will save money, time and rises success rates
  • Building Unified Models will support the estimation of future behavior of compounds and their performance in confused clinical trials. Mainly, there are 2 stages which are accessible: estimating toxicity and estimating efficacy of combined therapies.
  • The rise of personalized medicine has created opportunities for AI to enhance the care provided to patients.

Life Sciences Artificial Intelligence (AI) Market Segment Analysis - By Process

Currently, Artificial Intelligence (AI) is in the growing stage, but it is showing significant growth in life sciences industry in the upcoming future due to rising application in initiating drug development. A particular focus is on third wave processes. As, Life Sciences are full of high-end processes, Artificial Intelligence is used to manage, gather and very nicely utilize all the structured and unstructured data. Implementing artificial intelligence with life sciences industry is growing rapidly, and now with the chance to transfer old processes over discovery, enhancement, manufacturing and regulation, to take medicines immediately to the patients. Very tough drug discovery and computational bio and chemistry modeling influenced by AI, hold significant potential to deliver early insights into the workings of the drugs. This will automatically enhance business performance and downstream effort especially with regards to clinical research and drug development.

Life Sciences Artificial Intelligence (AI) Market Segment Analysis - By Application

Drug Discovery is set to dominate the market and grow at a CAGR of 14.8% through the forecast period. The application of drug discovery for identification of unmet medical needs, target identification, personalized medicine, lead optimization and so on in the healthcare sector will propel the life sciences AI market. Tough medication revelation and computational bio and science demonstrating is highly influenced by AI, hold critical potential to convey early bits of knowledge into the activities of the medications. This will consequently improve business execution and downstream exertion. In addition, as Life Sciences are full of high-end processes, Artificial Intelligence is used to manage, gather and very nicely utilize all the structured and unstructured data, thus enhancing the drug development processes.

Life Sciences Artificial Intelligence (AI) Market - By Geography 

North America region dominated the global life sciences AI market as of 2020. It is due to the presence of significant players namely TwoXAR Pharmaceuticals, NuMedii, Numerate, Inc. and IBM Corporation. These players are focusing on their offerings of advanced platform for the life science industry. The advanced AI platform establishes enhanced drug development programs thus reshaping the life science industry. The pharmaceutical companies are also looking for partnerships, collaboration and joint venture with the AI startups for enhancing the deployment of AI –based technologies in the life sciences market.

Life Sciences Artificial Intelligence (AI) Market, By Region, 2020 (%)

Life Sciences Artificial Intelligence (AI) Market, By Region, 2020

Life Sciences AI Market Drivers

Acceleration of Advanced Diagnostics and Drug Development

With the deployment of AI in life sciences industry the healthcare is widely being enhanced which is leading to the acceleration of drug development, and further employment of advanced technology for patient diagnosis. The implementation of histopathology image analysis and automated diagnosis, along with the technological process such as digitalization that permits all microscopic magnifications are widely accelerating the life sciences AI market. In addition, the rising use of AI for pattern recognition, combined with complex algorithms and automated immunohistochemically measurement systems, has provided pathologists the ability to analyze more critical patients cases and offer improved personalized medicine. This involvement of AI for critical diagnosis of patients health will prove to provide a positive impact on market growth. The rising advancements in AI and machine learning for the reduction in the time taken for the development, manufacture and launch of latest patient therapies and for reducing the timelines for the overall product development is also driving the life sciences AI market. Recently, scientists are integrating research data, lab data, and clinical data, with new information sources that includes social media and wearables for the process of drug development and also creating a holistic picture of the drug development candidate. Thus, the need for improved ways for acquiring and extracting data in real-time to scientists leads to the extensive use of AI and machine learning. The adoption of AI and machine learning by scientists also makes the decision for drug development more improved and faster, which will accelerate the product development and scale-up process further enhancing the Life Sciences AI market.

Emerging Machine Learning, and Clinical Site Selection along with the Acceleration of Patient Identification

Machine Learning in the healthcare industry has become an important tool for providing up-to-date information on the safety of the products used in healthcare. Most of life science companies are looking forward to enhance pharmaceutical labels (e.g., package insert, patient information leaflets) in an important way to communicate safety information especially in providing personalized medicine. This factor is also leading to requirement of an updated reference label that is necessary for safety reasons, and include multiple considerations such as artwork printing, production run dates and so on for submitting the local product label to the corresponding health authority. Furthermore, companies’ SOP timelines govern submission due dates which are more stringent than what health authorities require, increasing workload and cost. Thus, with the combination of collected data points by the company along with machine learning helps to determine an optimal submission date for the products and leading to the safety of the products.

Life Sciences AI Market Challenges

Lack of Skilled Workforce and Data Issues

in the recent time, as technology is upgrading the need for skilled workforce is also increasing, but majority of the industries are lagging behind in the adoption of new technologies due to the insufficient skilled workforce. The life science industry is also among those industries which is facing challenges in the adoption of AI and other innovative technology, as majority of the highly skilled AI developers are not interested to work in the life sciences industry further hampering the growth of the market. This key factor is also further leading to the requirement of more creative strategies adopted by pharma companies for attracting and retaining AI talent. The other key challenge that is hindering the adoption of machine learning and AI in life science industry is the access of data, which is also regarded as the biggest barrier affecting the growth of the market. According to the Pistoia Alliance, in 2019, scientists identified that more than 24 percent of respondents referred to access to information as the greatest test to AI adoption, and 30 percent referred to absence of skill for performing AI based machine learning and deep learning. In spite of these hindrances, utilization of AI in the existence sciences has expanded in the previous two years, with 70 percent of respondents expressing they are utilizing AI, including AI and profound learning, in some limit, up from 44 percent in 2018.

Market Landscape

Product launches, acquisitions, and R&D activities are key strategies adopted by players in the Life Sciences AI Market. TwoXAR, Numerate, NuMedii, IBM, and Envisagenics and others are considered to be the key players of the Life Sciences AI Market

Acquisitions/Technology Launches/Partnerships

  • In January 2021, Harlow-based colocation provider Kao Data has added artificial intelligence (AI)-focused startup InstaDeep to its customer roster of high-performance computing (HPC) clients.
  • In January 2021, Bioclinica, a solutions provider of clinical life science and technology expertise, has acquired Silicon Valley-based Saliency. Bioclinica will integrate the company's AI technology into its imaging platform to support a growing portfolio of pharmaceutical and medical device clients.

Related Reports:

Report Code: HCR 27493

Report Code: ITR 0075

For more Information and Communications Technology related reports, please click here
1. Life Sciences Artificial Intelligence Market Overview
    1.1 Definitions and Scope
2. Life Sciences Artificial Intelligence Market   - Executive Summary
    2.1 Market Revenue, Market Size and Key Trends by Company
    2.2 Key trends By Process
    2.3 Key trends By End Use Industry
    2.4 Key trends segmented by Geography
3. Life Sciences Artificial Intelligence Market – Market Landscape
    3.1 Comparative Analysis
        3.1.1 Product/Company Benchmarking-Top 5 Companies
        3.1.2 Top 5 Financial Analysis
        3.1.3 Market Value Split by Top 5 Companies
        3.1.4 Patent Analysis
        3.1.5 Pricing Analysis (Comparison of General Price of Industry Solutions)
4. Life Sciences Artificial Intelligence Market – Industry Market Entry Scenario Premium (Premium)
    4.1 Regulatory Scenario
    4.2 Ease of Doing Business Index
    4.3 Case Studies
    4.4 Customer Analysis
5. Life Sciences Artificial Intelligence Market – Startup Company Scenario (Premium)
    5.1 Venture Capital and Funding Scenario
    5.2 Startup Company Analysis
6. Life Sciences Artificial Intelligence Market - Market Forces
    6.1 Market Drivers
    6.2 Market Constraints
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Life Sciences Artificial Intelligence Market – By Strategic Analysis (Market Size -$Million/Billion)
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Product Life Cycle/Market Life Cycle Analysis
8. Life Sciences Artificial Intelligence Market – By Process (Market Size -$Million/Billion)
    8.1 First Wave
    8.2 Second Wave
    8.3 Third Wave
9. Life Sciences Artificial Intelligence Market – By Type (Market Size -$Million/Billion)
    9.1 Machine Learning
    9.2 Deep Learning
    9.3 Neural Networks
10. Life Sciences Artificial Intelligence Market – By Industry Vertical (Market Size -$Million/Billion)
    10.1 Drug Discovery
    10.2 Pre-Clinical
    10.3 Clinical
    10.4 Drug Approval
    10.5 Patient Monitoring
    10.6 Others
11. Life Sciences Artificial Intelligence Market - By Geography (Market Size -$Million/Billion)
    11.1 North America
        11.1.1 U.S
        11.1.2 Canada
        11.1.3 Mexico
    11.2 South America
        11.2.1 Brazil
        11.2.2 Argentina
        11.2.3 Chile
        11.2.4 Colombia
        11.2.5 Others
    11.3 Europe
        11.3.1 Germany
        11.3.2 France
        11.3.3 UK
        11.3.4 Italy
        11.3.5 Spain
        11.3.6 Russia
        11.3.7 Netherlands
        11.3.8 Others
    11.4 APAC
        11.4.1 China
        11.4.2 Japan
        11.4.3 South Korea
        11.4.4 India
        11.4.5 Australia
        11.4.6 Indonesia
        11.4.7 Malaysia
        11.4.8 Others
    11.5 RoW
        11.5.1 Middle East
        11.5.2 Africa
12. Life Sciences Artificial Intelligence Market - Market Entropy
    12.1 New product launches
    12.2 M&A's, collaborations, JVs and partnerships
13. Life Sciences Artificial Intelligence Market – Industry Competitive Landscape (Premium)
    13.1 Market Share – Global
    13.2 Market Share by Region
    13.3 Market Share By Industry Vertical
    13.4 Market Share By Process
14. Life Sciences Artificial Intelligence Market – Key Company List by Country Premium (Premium)
15. Life Sciences Artificial Intelligence Market - Company Analysis
    15.1 Company 1
    15.2 Company 2
    15.3 Company 3
    15.4 Company 4
    15.5 Company 5
    15.6 Company 6
    15.7 Company 7
    15.8 Company 8
    15.9 Company 9
    15.10 Company 10
List of Tables

Table 1: Life Sciences Artificial Intelligence (AI) Market Overview 2019-2024
Table 2: Life Sciences Artificial Intelligence (AI) Market Leader Analysis 2018-2019 (US$)
Table 3: Life Sciences Artificial Intelligence (AI) Market Product Analysis 2018-2019 (US$)
Table 4: Life Sciences Artificial Intelligence (AI) Market End User Analysis 2018-2019 (US$)
Table 5: Life Sciences Artificial Intelligence (AI) Market Patent Analysis 2013-2018* (US$)
Table 6: Life Sciences Artificial Intelligence (AI) Market Financial Analysis 2018-2019 (US$)
Table 7: Life Sciences Artificial Intelligence (AI) Market Driver Analysis 2018-2019 (US$)
Table 8: Life Sciences Artificial Intelligence (AI) Market Challenges Analysis 2018-2019 (US$)
Table 9: Life Sciences Artificial Intelligence (AI) Market Constraint Analysis 2018-2019 (US$)
Table 10: Life Sciences Artificial Intelligence (AI) Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Life Sciences Artificial Intelligence (AI) Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Life Sciences Artificial Intelligence (AI) Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Life Sciences Artificial Intelligence (AI) Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Life Sciences Artificial Intelligence (AI) Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Life Sciences Artificial Intelligence (AI) Market Value Chain Analysis 2018-2019 (US$)
Table 16: Life Sciences Artificial Intelligence (AI) Market Pricing Analysis 2019-2024 (US$)
Table 17: Life Sciences Artificial Intelligence (AI) Market Opportunities Analysis 2019-2024 (US$)
Table 18: Life Sciences Artificial Intelligence (AI) Market Product Life Cycle Analysis 2019-2024 (US$)
Table 19: Life Sciences Artificial Intelligence (AI) Market Supplier Analysis 2018-2019 (US$)
Table 20: Life Sciences Artificial Intelligence (AI) Market Distributor Analysis 2018-2019 (US$)
Table 21: Life Sciences Artificial Intelligence (AI) Market Trend Analysis 2018-2019 (US$)
Table 22: Life Sciences Artificial Intelligence (AI) Market Size 2018 (US$)
Table 23: Life Sciences Artificial Intelligence (AI) Market Forecast Analysis 2019-2024 (US$)
Table 24: Life Sciences Artificial Intelligence (AI) Market Sales Forecast Analysis 2019-2024 (Units)
Table 25: Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 26: Life Sciences Artificial Intelligence (AI) Market By Type, Revenue & Volume, By Machine Learning, 2019-2024 ($)
Table 27: Life Sciences Artificial Intelligence (AI) Market By Type, Revenue & Volume, By Deep Learning, 2019-2024 ($)
Table 28: Life Sciences Artificial Intelligence (AI) Market By Type, Revenue & Volume, By Neural Networks, 2019-2024 ($)
Table 29: Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 30: Life Sciences Artificial Intelligence (AI) Market By process, Revenue & Volume, By First Wave, 2019-2024 ($)
Table 31: Life Sciences Artificial Intelligence (AI) Market By process, Revenue & Volume, By Second Wave, 2019-2024 ($)
Table 32: Life Sciences Artificial Intelligence (AI) Market By process, Revenue & Volume, By Third Wave, 2019-2024 ($)
Table 33: Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 34: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Drug Discovery, 2019-2024 ($)
Table 35: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Pre -Clinical, 2019-2024 ($)
Table 36: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Clinical, 2019-2024 ($)
Table 37: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Drug Approval, 2019-2024 ($)
Table 38: Life Sciences Artificial Intelligence (AI) Market By End User Application, Revenue & Volume, By Patient Monitoring, 2019-2024 ($)
Table 39: North America Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 40: North America Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 41: North America Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 42: South america Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 43: South america Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 44: South america Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 45: Europe Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 46: Europe Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 47: Europe Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 48: APAC Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 49: APAC Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 50: APAC Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 51: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 52: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 53: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 54: Russia Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 55: Russia Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 56: Russia Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 57: Israel Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By Type, 2019-2024 ($)
Table 58: Israel Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By process, 2019-2024 ($)
Table 59: Israel Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume, By End User Application, 2019-2024 ($)
Table 60: Top Companies 2018 (US$)Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume
Table 61: Product Launch 2018-2019Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume
Table 62: Mergers & Acquistions 2018-2019Life Sciences Artificial Intelligence (AI) Market, Revenue & Volume
List of Figures

Figure 1: Overview of Life Sciences Artificial Intelligence (AI) Market 2019-2024
Figure 2: Market Share Analysis for Life Sciences Artificial Intelligence (AI) Market 2018 (US$)
Figure 3: Product Comparison in Life Sciences Artificial Intelligence (AI) Market 2018-2019 (US$)
Figure 4: End User Profile for Life Sciences Artificial Intelligence (AI) Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Life Sciences Artificial Intelligence (AI) Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Life Sciences Artificial Intelligence (AI) Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Life Sciences Artificial Intelligence (AI) Market 2018-2019
Figure 8: Ecosystem Analysis in Life Sciences Artificial Intelligence (AI) Market 2018
Figure 9: Average Selling Price in Life Sciences Artificial Intelligence (AI) Market 2019-2024
Figure 10: Top Opportunites in Life Sciences Artificial Intelligence (AI) Market 2018-2019
Figure 11: Market Life Cycle Analysis in Life Sciences Artificial Intelligence (AI) Market
Figure 12: GlobalBy TypeLife Sciences Artificial Intelligence (AI) Market Revenue, 2019-2024 ($)
Figure 13: GlobalBy processLife Sciences Artificial Intelligence (AI) Market Revenue, 2019-2024 ($)
Figure 14: GlobalBy End User Application Life Sciences Artificial Intelligence (AI) Market Revenue, 2019-2024 ($)
Figure 15: Global Life Sciences Artificial Intelligence (AI) Market - By Geography
Figure 16: Global Life Sciences Artificial Intelligence (AI) Market Value & Volume, By Geography, 2019-2024 ($) 
Figure 17: Global Life Sciences Artificial Intelligence (AI) Market CAGR, By Geography, 2019-2024 (%)
Figure 18: North America Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 19: US Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 20: US GDP and Population, 2018-2019 ($)
Figure 21: US GDP – Composition of 2018, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2018-2019 ($)
Figure 23: Canada Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 24: Canada GDP and Population, 2018-2019 ($)
Figure 25: Canada GDP – Composition of 2018, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 27: Mexico Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 28: Mexico GDP and Population, 2018-2019 ($)
Figure 29: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 31: South America Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 32: Brazil Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 33: Brazil GDP and Population, 2018-2019 ($)
Figure 34: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 36: Venezuela Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 37: Venezuela GDP and Population, 2018-2019 ($)
Figure 38: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 40: Argentina Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 41: Argentina GDP and Population, 2018-2019 ($)
Figure 42: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 44: Ecuador Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 45: Ecuador GDP and Population, 2018-2019 ($)
Figure 46: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 48: Peru Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 49: Peru GDP and Population, 2018-2019 ($)
Figure 50: Peru GDP – Composition of 2018, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 52: Colombia Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 53: Colombia GDP and Population, 2018-2019 ($)
Figure 54: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 56: Costa Rica Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 57: Costa Rica GDP and Population, 2018-2019 ($)
Figure 58: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 60: Europe Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 61: U.K Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 62: U.K GDP and Population, 2018-2019 ($)
Figure 63: U.K GDP – Composition of 2018, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 65: Germany Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 66: Germany GDP and Population, 2018-2019 ($)
Figure 67: Germany GDP – Composition of 2018, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 69: Italy Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 70: Italy GDP and Population, 2018-2019 ($)
Figure 71: Italy GDP – Composition of 2018, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 73: France Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 74: France GDP and Population, 2018-2019 ($)
Figure 75: France GDP – Composition of 2018, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2018-2019 ($)
Figure 77: Netherlands Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 78: Netherlands GDP and Population, 2018-2019 ($)
Figure 79: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 81: Belgium Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 82: Belgium GDP and Population, 2018-2019 ($)
Figure 83: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 85: Spain Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 86: Spain GDP and Population, 2018-2019 ($)
Figure 87: Spain GDP – Composition of 2018, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 89: Denmark Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 90: Denmark GDP and Population, 2018-2019 ($)
Figure 91: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 93: APAC Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 94: China Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024
Figure 95: China GDP and Population, 2018-2019 ($)
Figure 96: China GDP – Composition of 2018, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2018-2019 ($)Life Sciences Artificial Intelligence (AI) Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 98: Australia Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 99: Australia GDP and Population, 2018-2019 ($)
Figure 100: Australia GDP – Composition of 2018, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 102: South Korea Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 103: South Korea GDP and Population, 2018-2019 ($)
Figure 104: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 106: India Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 107: India GDP and Population, 2018-2019 ($)
Figure 108: India GDP – Composition of 2018, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2018-2019 ($)
Figure 110: Taiwan Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 111: Taiwan GDP and Population, 2018-2019 ($)
Figure 112: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 114: Malaysia Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 115: Malaysia GDP and Population, 2018-2019 ($)
Figure 116: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 118: Hong Kong Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 119: Hong Kong GDP and Population, 2018-2019 ($)
Figure 120: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 122: Middle East & Africa Life Sciences Artificial Intelligence (AI) Market Middle East & Africa 3D Printing Market Value & Volume, 2019-2024 ($)
Figure 123: Russia Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 124: Russia GDP and Population, 2018-2019 ($)
Figure 125: Russia GDP – Composition of 2018, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 127: Israel Life Sciences Artificial Intelligence (AI) Market Value & Volume, 2019-2024 ($)
Figure 128: Israel GDP and Population, 2018-2019 ($)
Figure 129: Israel GDP – Composition of 2018, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 131: Entropy Share, By Strategies, 2018-2019* (%)Life Sciences Artificial Intelligence (AI) Market 
Figure 132: Developments, 2018-2019*Life Sciences Artificial Intelligence (AI) Market 
Figure 133: Company 1 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 134: Company 1 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 135: Company 1 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 136: Company 2 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 137: Company 2 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 138: Company 2 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 139: Company 3 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 140: Company 3 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 141: Company 3 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 142: Company 4 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 143: Company 4 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 144: Company 4 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 145: Company 5 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 146: Company 5 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 147: Company 5 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 148: Company 6 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 149: Company 6 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 150: Company 6 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 151: Company 7 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 152: Company 7 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 153: Company 7 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 154: Company 8 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 155: Company 8 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 156: Company 8 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 157: Company 9 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 158: Company 9 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 159: Company 9 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 160: Company 10 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 161: Company 10 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 162: Company 10 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 163: Company 11 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 164: Company 11 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 165: Company 11 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 166: Company 12 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 167: Company 12 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 168: Company 12 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 169: Company 13 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 170: Company 13 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 171: Company 13 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 172: Company 14 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 173: Company 14 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 174: Company 14 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)
Figure 175: Company 15 Life Sciences Artificial Intelligence (AI) Market Net Revenue, By Years, 2018-2019* ($)
Figure 176: Company 15 Life Sciences Artificial Intelligence (AI) Market Net Revenue Share, By Business segments, 2018 (%)
Figure 177: Company 15 Life Sciences Artificial Intelligence (AI) Market Net Sales Share, By Geography, 2018 (%)